1 / 3

Macrolide Antibiotics Market is Trending with CAGR of 12.5% by 2023

A Broad Analysis of the "Worldwide Macrolide Antibiotics market “methodology of the leading organizations in the exactness of import/export utilization, market activity figures, cost, value, revenue and gross edges.

karishma7800
Download Presentation

Macrolide Antibiotics Market is Trending with CAGR of 12.5% by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Macrolide antibiotics Market -Highlights Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis. It acts as a bacteriostatic agent against many strains of corynebacteria, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections as well as mouth and dental infections. They are also used as an alternative to penicillin. Macrolide antibiotics Market- Growth and Analysis The global macrolide antibiotics market is expected to show a sharp growth over the forecast period owing to an increasing demand for macrolide across the globe. Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favor the market growth. According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the assessment period. The global macrolide antibiotics market is expected to grow at a CAGR of 12.5% during the forecast period 2017-2023. Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “macrolide antibiotics market research report–Global forecast till 2023.” Macrolide antibiotics Market -Major Key Players Merck Sharp & Dohme Corp (U.S.) Pfizer Inc. (U.S.) Neo Química (Brazil) Macrolide Pharmaceuticals (U.S.) Teva Pharmaceutical Industries Ltd. (Israel) Fresenius Kabi USA (U.S.) Sandoz International GmbH (Germany) Gland Pharma Limited (India) Mylan N.V. (U.S.) WOCKHARDT (U.S.) Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/4342 Macrolide antibiotics Market -Regional Analysis

  2. The global macrolide antibiotics market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas dominates the global macrolide antibiotics market. It comprises of two regions namely North America and South America. In Europe, increasing use of azithromycin, and erythromycin has led to the rise in the demand for the macrolide antibiotics. France accounts for the largest market share followed by Germany owing to the increasing incidence of skin diseases. Expansion of healthcare system in developing countries in Asia Pacific also favors the market growth. The Middle East & Africa is expected to witness a steady growth in this market. Macrolide antibiotics Market -Segmentation The global macrolide antibiotics market is segmented on the basis of drugs, which includes azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin. On the basis of route of administration, the market is segmented into oral, parenteral. On the basis of indication, the market is segmented into infection due to mycoplasma pneumoniae, legionella sp, or bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, peliosis hepatis in patients with AIDS, cerebral toxoplasmosis, uncomplicated skin infections, and others. On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmaceutical companies, and others. Global Macrolide Antibiotics -Major Points from TOC Chapter 1. Report Prologue Chapter 2. Market Introduction Chapter 3. Research Methodology Chapter 4. Market Dynamics Chapter 5. Market Factor Analysis Chapter 6. Global Macrolide Antibiotics Market, By Type Chapter 7. Global Macrolide Antibiotics Market, By Treatment Chapter 8 Global Macrolide Antibiotics Market, By End User Chapter 9. Global Macrolide Antibiotics Market, By Region Chapter 10 Company Landscape Chapter 11 Company Profiles Chapter 12 MRFR Conclusion Chapter 13 Appendix Avail Attractive @ https://www.marketresearchfuture.com/check-discount/4342 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

  3. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com

More Related